WHO-5 and BDI-II are acceptable screening instruments for depression in people with diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

WHO-5 and BDI-II are acceptable screening instruments for depression in people with diabetes

Published:2018-09-21 Issue:12 Volume:35 Page:1678-1685
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Rauwerda N. L.¹^ORCID,Tovote K. A.²,Peeters A. C. T. M.³,Sanderman R.²⁴,Emmelkamp P. M. G.⁵,Schroevers M. J.²,Fleer J.²

Affiliation:

1. Department of Medical Psychology; Hospital Gelderse Vallei; Ede The Netherlands

2. Department of Health Psychology, University Medical Centre Groningen; University of Groningen; Groningen The Netherlands

3. Department of Internal Medicine; Hospital Rivierenland; Tiel The Netherlands

4. Department of Psychology, Health and Technology; University of Twente; Enschede The Netherlands

5. Department of Clinical Psychology; University of Amsterdam and Netherlands Institute for Advanced Study; Amsterdam The Netherlands

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.13779/fullpdf

Reference23 articles.

1. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis;Ali;Diabet Med,2006

2. Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands;Pouwer;Diabet Med,2010

3. Depression and poor glycemic control: a meta-analytic review of the literature;Lustman;Diabetes Care,2000

4. Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium;Schram;Curr Diabetes Rev,2009

5. Nurses’ recognition and registration of depression, anxiety and diabetes specific emotional problems in outpatients with diabetes mellitus;Pouwer;Patient Educ Couns,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes;Journal of Diabetes and its Complications;2024-09

2. Development and Validation of a Community–Based Prediction Model for Depression in Elderly Patients with Diabetes: A Cross–Sectional Study;Diabetes, Metabolic Syndrome and Obesity;2024-07

3. Validation and Optimal Cut-Off Score of the World Health Organization Well- being Index (WHO-5) as a Screening Tool for Depression among Patients with Schizophrenia;2024-03-11

4. Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis;CNS Spectrums;2024-03-08

5. Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals;BMJ Mental Health;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3